159 related articles for article (PubMed ID: 24261607)
1. ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF-dependent mechanism.
Gandhi C; Ahmad A; Wilson KM; Chauhan AK
J Thromb Haemost; 2014 Feb; 12(2):255-60. PubMed ID: 24261607
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice.
Gandhi C; Khan MM; Lentz SR; Chauhan AK
Blood; 2012 Mar; 119(10):2385-91. PubMed ID: 22123843
[TBL] [Abstract][Full Text] [Related]
4. Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model.
Jin SY; Tohyama J; Bauer RC; Cao NN; Rader DJ; Zheng XL
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1817-23. PubMed ID: 22652598
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice.
Khan MM; Motto DG; Lentz SR; Chauhan AK
J Thromb Haemost; 2012 Aug; 10(8):1665-71. PubMed ID: 22712744
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice.
Gandhi C; Motto DG; Jensen M; Lentz SR; Chauhan AK
Blood; 2012 Dec; 120(26):5224-30. PubMed ID: 22983446
[TBL] [Abstract][Full Text] [Related]
7. Endothelial CD40 Mediates Microvascular von Willebrand Factor-Dependent Platelet Adhesion Inducing Inflammatory Venothrombosis in ADAMTS13 Knockout Mice.
Tahir S; Wagner AH; Dietzel S; Mannell H; Pircher J; Weckbach LT; Hecker M; Pohl U
Thromb Haemost; 2020 Mar; 120(3):466-476. PubMed ID: 32135568
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
[TBL] [Abstract][Full Text] [Related]
9. ADAMTS13-von Willebrand factor axis is involved in the pathophysiology of kidney ischaemia-reperfusion injury.
Kim MG; Lim SY; Ko YS; Lee HY; Jo SK; Cho WY
Nephrology (Carlton); 2017 Nov; 22(11):913-920. PubMed ID: 27507004
[TBL] [Abstract][Full Text] [Related]
10. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS13: a new link between thrombosis and inflammation.
Chauhan AK; Kisucka J; Brill A; Walsh MT; Scheiflinger F; Wagner DD
J Exp Med; 2008 Sep; 205(9):2065-74. PubMed ID: 18695007
[TBL] [Abstract][Full Text] [Related]
12. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
[TBL] [Abstract][Full Text] [Related]
13. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
Reiter RA; Knöbl P; Varadi K; Turecek PL
Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand Factor Aggravates Hepatic Ischemia-Reperfusion Injury by Promoting Neutrophil Recruitment in Mice.
Urisono Y; Sakata A; Matsui H; Kasuda S; Ono S; Yoshimoto K; Nishio K; Sho M; Akiyama M; Miyata T; Okuchi K; Nishimura S; Sugimoto M
Thromb Haemost; 2018 Apr; 118(4):700-708. PubMed ID: 29618155
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
16. Control of von Willebrand factor multimer size and implications for disease.
Pimanda J; Hogg P
Blood Rev; 2002 Sep; 16(3):185-92. PubMed ID: 12163004
[TBL] [Abstract][Full Text] [Related]
17. Shear stress and von Willebrand factor in health and disease.
Tsai HM
Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
[TBL] [Abstract][Full Text] [Related]
18. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
Bao J; Xiao J; Mao Y; Zheng XL
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.
Chen J; Reheman A; Gushiken FC; Nolasco L; Fu X; Moake JL; Ni H; López JA
J Clin Invest; 2011 Feb; 121(2):593-603. PubMed ID: 21266777
[TBL] [Abstract][Full Text] [Related]
20. The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis.
Chauhan AK; Walsh MT; Zhu G; Ginsburg D; Wagner DD; Motto DG
Blood; 2008 Apr; 111(7):3452-7. PubMed ID: 18083848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
